Long-term management of advanced basal cell carcinoma: current challenges and future perspectives
The first-line therapy for locally advanced basal cell carcinoma (laBCC) is Hedgehog pathway inhibitors (HHIs), as they achieve good efficacy and duration of response. However, toxicity in the course of long-term treatment may lead to a decrease in the quality of life, and consequently to interrupti...
Gespeichert in:
| Hauptverfasser: | , , , , , , |
|---|---|
| Dokumenttyp: | Article (Journal) |
| Sprache: | Englisch |
| Veröffentlicht: |
20 September 2022
|
| In: |
Cancers
Year: 2022, Jahrgang: 14, Heft: 19, Pages: 1-18 |
| ISSN: | 2072-6694 |
| DOI: | 10.3390/cancers14194547 |
| Online-Zugang: | Verlag, Volltext: https://doi.org/10.3390/cancers14194547 Verlag, Volltext: https://www.mdpi.com/2072-6694/14/19/4547 
|
| Verfasserangaben: | Markus V. Heppt, Christoffer Gebhardt, Jessica C. Hassel, Mareike Alter, Ralf Gutzmer, Ulrike Leiter and Carola Berking |
MARC
| LEADER | 00000caa a2200000 c 4500 | ||
|---|---|---|---|
| 001 | 1830800531 | ||
| 003 | DE-627 | ||
| 005 | 20230118113615.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 230111s2022 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.3390/cancers14194547 |2 doi | |
| 035 | |a (DE-627)1830800531 | ||
| 035 | |a (DE-599)KXP1830800531 | ||
| 035 | |a (OCoLC)1361669688 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rda | ||
| 041 | |a eng | ||
| 084 | |a 33 |2 sdnb | ||
| 100 | 1 | |a Heppt, Markus V. |d 1987- |e VerfasserIn |0 (DE-588)1072242346 |0 (DE-627)827081111 |0 (DE-576)43371767X |4 aut | |
| 245 | 1 | 0 | |a Long-term management of advanced basal cell carcinoma |b current challenges and future perspectives |c Markus V. Heppt, Christoffer Gebhardt, Jessica C. Hassel, Mareike Alter, Ralf Gutzmer, Ulrike Leiter and Carola Berking |
| 264 | 1 | |c 20 September 2022 | |
| 300 | |a 18 | ||
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a Computermedien |b c |2 rdamedia | ||
| 338 | |a Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Gesehen am 11.01.2023 | ||
| 520 | |a The first-line therapy for locally advanced basal cell carcinoma (laBCC) is Hedgehog pathway inhibitors (HHIs), as they achieve good efficacy and duration of response. However, toxicity in the course of long-term treatment may lead to a decrease in the quality of life, and consequently to interruption or even discontinuation of therapy. As HHI therapy is a balancing act between effectiveness, adverse events, quality of life, and adherence, numerous successful treatment strategies have evolved, such as dose reduction and dose interruptions with on-off treatment schedules or interruptions with re-challenge after progression. As a small percentage of patients show primary or acquired resistance to HHIs, the inhibition of programmed cell death protein 1 (PD-1) has been approved as a second-line therapy, which may also be accompanied by immune-related toxicities and non-response. Thus, optimization of current treatment schedules, novel agents, and combination strategies are urgently needed for laBCC. Here, we narratively model the treatment sequence for patients with laBCC and summarize the current state of approved treatment regimens and therapeutic strategies to optimize the long-term management of laBCC. | ||
| 650 | 4 | |a basal cell carcinoma | |
| 650 | 4 | |a Hedgehog pathway inhibitors | |
| 650 | 4 | |a immunotherapy | |
| 650 | 4 | |a programmed cell death protein 1 inhibitor | |
| 700 | 1 | |a Gebhardt, Christoffer |e VerfasserIn |4 aut | |
| 700 | 1 | |a Hassel, Jessica C. |d 1975- |e VerfasserIn |0 (DE-588)129790702 |0 (DE-627)480399069 |0 (DE-576)29783715X |4 aut | |
| 700 | 1 | |a Alter, Mareike |e VerfasserIn |4 aut | |
| 700 | 1 | |a Gutzmer, Ralf |e VerfasserIn |4 aut | |
| 700 | 1 | |a Leiter, Ulrike |e VerfasserIn |4 aut | |
| 700 | 1 | |a Berking, Carola |e VerfasserIn |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Cancers |d Basel : MDPI, 2009 |g 14(2022), 19, Artikel-ID 4547, Seite 1-18 |h Online-Ressource |w (DE-627)614095670 |w (DE-600)2527080-1 |w (DE-576)313958548 |x 2072-6694 |7 nnas |a Long-term management of advanced basal cell carcinoma current challenges and future perspectives |
| 773 | 1 | 8 | |g volume:14 |g year:2022 |g number:19 |g elocationid:4547 |g pages:1-18 |g extent:18 |a Long-term management of advanced basal cell carcinoma current challenges and future perspectives |
| 856 | 4 | 0 | |u https://doi.org/10.3390/cancers14194547 |x Verlag |x Resolving-System |3 Volltext |
| 856 | 4 | 0 | |u https://www.mdpi.com/2072-6694/14/19/4547 |x Verlag |3 Volltext |
| 951 | |a AR | ||
| 992 | |a 20230111 | ||
| 993 | |a Article | ||
| 994 | |a 2022 | ||
| 998 | |g 129790702 |a Hassel, Jessica C. |m 129790702:Hassel, Jessica C. |d 910000 |d 911300 |d 50000 |e 910000PH129790702 |e 911300PH129790702 |e 50000PH129790702 |k 0/910000/ |k 1/910000/911300/ |k 0/50000/ |p 3 | ||
| 999 | |a KXP-PPN1830800531 |e 4246059897 | ||
| BIB | |a Y | ||
| SER | |a journal | ||
| JSO | |a {"id":{"doi":["10.3390/cancers14194547"],"eki":["1830800531"]},"name":{"displayForm":["Markus V. Heppt, Christoffer Gebhardt, Jessica C. Hassel, Mareike Alter, Ralf Gutzmer, Ulrike Leiter and Carola Berking"]},"physDesc":[{"extent":"18 S."}],"recId":"1830800531","note":["Gesehen am 11.01.2023"],"type":{"bibl":"article-journal","media":"Online-Ressource"},"language":["eng"],"title":[{"title_sort":"Long-term management of advanced basal cell carcinoma","title":"Long-term management of advanced basal cell carcinoma","subtitle":"current challenges and future perspectives"}],"person":[{"display":"Heppt, Markus V.","role":"aut","given":"Markus V.","family":"Heppt"},{"family":"Gebhardt","given":"Christoffer","role":"aut","display":"Gebhardt, Christoffer"},{"role":"aut","given":"Jessica C.","family":"Hassel","display":"Hassel, Jessica C."},{"family":"Alter","given":"Mareike","role":"aut","display":"Alter, Mareike"},{"role":"aut","given":"Ralf","family":"Gutzmer","display":"Gutzmer, Ralf"},{"given":"Ulrike","role":"aut","family":"Leiter","display":"Leiter, Ulrike"},{"family":"Berking","given":"Carola","role":"aut","display":"Berking, Carola"}],"relHost":[{"physDesc":[{"extent":"Online-Ressource"}],"recId":"614095670","disp":"Long-term management of advanced basal cell carcinoma current challenges and future perspectivesCancers","origin":[{"publisher":"MDPI","dateIssuedDisp":"2009-","dateIssuedKey":"2009","publisherPlace":"Basel"}],"note":["Gesehen am 27.05.2020"],"type":{"media":"Online-Ressource","bibl":"periodical"},"language":["eng"],"title":[{"title_sort":"Cancers","title":"Cancers"}],"pubHistory":["1.2009 -"],"name":{"displayForm":["Molecular Diversity Preservation International (MDPI)"]},"part":{"year":"2022","volume":"14","pages":"1-18","issue":"19","extent":"18","text":"14(2022), 19, Artikel-ID 4547, Seite 1-18"},"id":{"zdb":["2527080-1"],"issn":["2072-6694"],"eki":["614095670"]}}],"origin":[{"dateIssuedKey":"2022","dateIssuedDisp":"20 September 2022"}]} | ||
| SRT | |a HEPPTMARKULONGTERMMA2020 | ||